136 related articles for article (PubMed ID: 30448567)
1. Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up study.
Luijten J; van Greevenbroek MMJ; Schaper NC; Meex SJR; van der Steen C; Meijer LJ; de Boer D; de Graaf J; Stehouwer CDA; Brouwers MCGJ
Atherosclerosis; 2019 Jan; 280():1-6. PubMed ID: 30448567
[TBL] [Abstract][Full Text] [Related]
2. Incidence of type 2 diabetes in familial combined hyperlipidemia.
Brouwers MCGJ; de Graaf J; Simons N; Meex S; Ten Doeschate S; van Heertum S; Heidemann B; Luijten J; de Boer D; Schaper N; Stehouwer CDA; van Greevenbroek MMJ
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32193201
[TBL] [Abstract][Full Text] [Related]
3. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
[TBL] [Abstract][Full Text] [Related]
4. Increased arterial stiffness in familial combined hyperlipidemia.
Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
[TBL] [Abstract][Full Text] [Related]
5. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass.
Keulen ET; Voors-Pette C; de Bruin TW
Am J Hypertens; 2001 Apr; 14(4 Pt 1):357-63. PubMed ID: 11336182
[TBL] [Abstract][Full Text] [Related]
6. Shared and non-shared familial susceptibility of coronary heart disease, ischemic stroke, peripheral artery disease and aortic disease.
Calling S; Ji J; Sundquist J; Sundquist K; Zöller B
Int J Cardiol; 2013 Oct; 168(3):2844-50. PubMed ID: 23642611
[TBL] [Abstract][Full Text] [Related]
7. Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity.
Voors-Pette C; de Bruin TW
Atherosclerosis; 2001 Aug; 157(2):481-9. PubMed ID: 11472750
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
[TBL] [Abstract][Full Text] [Related]
10. Abdominal obesity and expression of familial combined hyperlipidemia.
van der Kallen CJ; Voors-Pette C; de Bruin TW
Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review.
Taghizadeh E; Mardani R; Rostami D; Taghizadeh H; Bazireh H; Hayat SMG
J Cell Biochem; 2019 Jun; 120(6):8891-8898. PubMed ID: 30556165
[TBL] [Abstract][Full Text] [Related]
12. Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events.
Pauciullo P; Gentile M; Marotta G; Baiano A; Ubaldi S; Jossa F; Iannuzzo G; Faccenda F; Panico S; Rubba P
Atherosclerosis; 2009 Mar; 203(1):320-4. PubMed ID: 18760784
[TBL] [Abstract][Full Text] [Related]
13. FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY; Kuri-García A; Ríos-Ríos M; Vargas-Vázquez A; Cortés-Arroyo JE; Tapia-González G; Cruz-Bautista I; Aguilar-Salinas CA
Rev Invest Clin; 2018; 70(5):224-236. PubMed ID: 30307446
[TBL] [Abstract][Full Text] [Related]
14. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
[TBL] [Abstract][Full Text] [Related]
15. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.
Coon H; Singh N; Dunn D; Eckfeldt JH; Province MA; Hopkins PN; Weiss R; Hunt SC; Leppert MF;
Atherosclerosis; 2004 Jun; 174(2):357-62. PubMed ID: 15136067
[TBL] [Abstract][Full Text] [Related]
16. Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.
Trinder M; Vikulova D; Pimstone S; Mancini GBJ; Brunham LR
Atherosclerosis; 2022 Jan; 340():35-43. PubMed ID: 34906840
[TBL] [Abstract][Full Text] [Related]
17. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies.
Reiner AP; Carlson CS; Jenny NS; Durda JP; Siscovick DS; Nickerson DA; Tracy RP
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2736-42. PubMed ID: 17885212
[TBL] [Abstract][Full Text] [Related]
18. Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia.
Pei WD; Sun YH; Liu Q; Zheng WY; Zhang J; Zhang CY; Gong J; Hopkins PN; Hui RT; Liu LS; Yang YJ
Int J Cardiol; 2007 Feb; 115(3):293-6. PubMed ID: 16797745
[TBL] [Abstract][Full Text] [Related]
19. Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio.
Junyent M; Zambón D; Gilabert R; Cofán M; Núñez I; Ros E
Atherosclerosis; 2008 Apr; 197(2):740-6. PubMed ID: 17698072
[TBL] [Abstract][Full Text] [Related]
20. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
